Table 1 Clinicopathological characteristics of the BC patients
Breast Cancer Patients | Age (years) | Number (%) | ||||||
|---|---|---|---|---|---|---|---|---|
 ≥ 45 | 10 (62.5%) | |||||||
 < 45 | 6 (37.5%) | |||||||
Invasive carcinoma histological grade | I | 0 (0%) | Tumor Stage (size of tumour) | T1 | 2 (12.5%) | Has the tumor spread to the lymph nodes? | N0 | (0%) |
II | 13 (81.25%) | T2 | 7 (43.75%) | N1 | 14 (87.5%) | |||
III | 2 (12.5%) | T3 | 2 (12.5%) | N2 | 1 (6.25%) | |||
Unk | 1 (6.25%) | T4 | 5 (31.25%) | N3 | 1 (6.25%) | |||
Lymph node metastases | M0 | 9 (56.25%) | Molecular Subtype | Luminal A | 12 (75%) | |||
Mx | 7 (43.75%) | Non-luminal Her2 +  | 4 (25%) | |||||
ER status |  + ve | 12 (75%) | PR status |  + ve | 12 (75%) | Her2/neu status |  + ve | 12 (75%) |
-ve | 4 (25%) | -ve | 4 (25%) | -ve | 4 (25%) | |||